NM_000071.3:c.1332C>T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong
The NM_000071.3(CBS):c.1332C>T(p.Asp444Asp) variant causes a synonymous change. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: not found (cov: 0)
Consequence
CBS
NM_000071.3 synonymous
NM_000071.3 synonymous
Scores
3
Clinical Significance
Conservation
PhyloP100: 5.32
Publications
1 publications found
Genes affected
CBS (HGNC:1550): (cystathionine beta-synthase) The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]
CBS Gene-Disease associations (from GenCC):
- classic homocystinuriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Myriad Women’s Health, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP6
Variant 21-43058860-G-A is Benign according to our data. Variant chr21-43058860-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 413355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000071.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CBS | MANE Select | c.1332C>T | p.Asp444Asp | synonymous | Exon 14 of 17 | NP_000062.1 | P35520-1 | ||
| CBS | c.1332C>T | p.Asp444Asp | synonymous | Exon 14 of 17 | NP_001171479.1 | P35520-1 | |||
| CBS | c.1332C>T | p.Asp444Asp | synonymous | Exon 14 of 18 | NP_001171480.1 | P35520-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CBS | TSL:1 MANE Select | c.1332C>T | p.Asp444Asp | synonymous | Exon 14 of 17 | ENSP00000381231.4 | P35520-1 | ||
| CBS | TSL:1 | c.1332C>T | p.Asp444Asp | synonymous | Exon 14 of 17 | ENSP00000344460.5 | P35520-1 | ||
| CBS | TSL:1 | c.1332C>T | p.Asp444Asp | synonymous | Exon 14 of 18 | ENSP00000352643.3 | P35520-1 |
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD3 genomes
Cov.:
0
GnomAD2 exomes AF: 0.00000595 AC: 1AN: 168062 AF XY: 0.0000112 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
168062
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome Cov.: 0
GnomAD4 genome
Cov.:
0
ClinVar
ClinVar submissions
View on ClinVar Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
1
Familial thoracic aortic aneurysm and aortic dissection (1)
-
-
1
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.